Informationen:
Fehler:
ID
12943
Beschreibung
Genetic Markers in Patients With Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00014079
Link
https://clinicaltrials.gov/show/NCT00014079
Stichworte
Versionen (1)
- 07.01.16 07.01.16 -
Rechteinhaber
CC BY-NC 3.0
Hochgeladen am
7. Januar 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Colorectal Cancer NCT00014079
Eligibility Colorectal Cancer NCT00014079
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Colorectal Cancer NCT00014079
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
adenocarcinoma of the colon
Item
must have had a resectable adenocarcinoma of the colon or rectum and must have participated in one of the following ncctg randomized clinical trials:
boolean
C0699790 (UMLS CUI [1])
784852
Item
784852: no treatment control versus levamisole versus levamisole plus fluorouracil (5-fu)
boolean
C0023556 (UMLS CUI [1])
C0016360 (UMLS CUI [2])
C0016360 (UMLS CUI [2])
794604
Item
794604: no treatment control versus 5-fu by portal vein infusion
boolean
C0016360 (UMLS CUI [1])
794751
Item
794751: postoperative radiation versus postoperative radiation plus sequential chemotherapy with methyl ccnu and 5-fu
boolean
C1522449 (UMLS CUI [1])
C0023972 (UMLS CUI [2])
C0016360 (UMLS CUI [3])
C0023972 (UMLS CUI [2])
C0016360 (UMLS CUI [3])
844652
Item
844652: an intergroup study - an evaluation of levamisole plus 5-fu as surgical adjuvant treatment for resectable adenocarcinoma of the colon
boolean
C0023556 (UMLS CUI [1])
C0016360 (UMLS CUI [2])
C0016360 (UMLS CUI [2])
864751
Item
864751: phase iii protocol for surgical adjuvant therapy of rectal carcinoma: a controller evaluation of (a) protracted-infusion 5-fu as a radiation enhancer and (b) 5-fu plus methyl-ccnu chemotherapy
boolean
C0543467 (UMLS CUI [1])
C0016360 (UMLS CUI [2])
C0023972 (UMLS CUI [3])
C0016360 (UMLS CUI [2])
C0023972 (UMLS CUI [3])
874651
Item
874651: m/n - a controller evaluation of recombinant interferon-gamma (ifl gm) and 5-fu and folinic acid with or without levamisole as adjuvant treatment for resectable adenocarcinoma of the colon
boolean
C2757040 (UMLS CUI [1])
C0016360 (UMLS CUI [2])
C0016410 (UMLS CUI [3])
C0023556 (UMLS CUI [4])
C0016360 (UMLS CUI [2])
C0016410 (UMLS CUI [3])
C0023556 (UMLS CUI [4])
894651
Item
894651: a controller phase iii evaluation of 5-fu combined with levamisole and leucovorin as adjuvant treatment for resectable colon cancer
boolean
C0016360 (UMLS CUI [1])
C0023556 (UMLS CUI [2])
C0023413 (UMLS CUI [3])
C0023556 (UMLS CUI [2])
C0023413 (UMLS CUI [3])
tissue blocks from the primary colorectal cancer must have been received by the ncctg operations office
Item
tissue blocks from the primary colorectal cancer must have been received by the ncctg operations office
boolean
C0040300 (UMLS CUI [1])